ArticleBMC cancer2016

IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.

Philippos Perimenis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.